chrisvoncsefalvay/vaers-outcomes huggingface dataset:
feels better; still felt tired; felt like a wet dishrag; feeling tired, arms tired; This spontaneous case was reported by a consumer and describes the occurrence of FEELING OF RELAXATION (feels better), ASTHENIA (felt like a wet dishrag), FATIGUE (feeling tired, arms tired) and FATIGUE (still felt tired) in an 84-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 01-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Apr-2021, the patient experienced ASTHENIA (felt like a wet dishrag) and FATIGUE (feeling tired, arms tired). On 06-Apr-2021, the patient experienced FATIGUE (still felt tired). On 08-Apr-2021, the patient experienced FEELING OF RELAXATION (feels better). At the time of the report, FEELING OF RELAXATION (feels better), ASTHENIA (felt like a wet dishrag), FATIGUE (feeling tired, arms tired) and FATIGUE (still felt tired) had resolved.            Concomitant medication was not provided Treatment information was not provided  The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) was not applicable  Patient reported they are fine now, further follow up is not required.  Patient denied further follow up.   Most recent FOLLOW-UP information incorporated above includes: On 10-May-2021: follow up received on 10 may 2021 stated that Patient reported they are fine now, further follow up is not required..
Pt received typhoid, flu and Hep-A vaccines and approx. 30 seconds, post vax, pt had a syncopal episode with duration of 45 seconds to 1-2 minutes.
Itching and rash developed a day or two after the injection and has continued for two weeks. It has gotten somewhat better but still persists.
Information has been received from a registered nurse concerning a 41 year old male patient with bicuspid aortic valve and no illness at time of vaccination who on 14-SEP-2010 03:00 PM was vaccinated IM into the left deltoid with the first dose of PNEUMOVAX 23 (lot number 667136/0499Z), and a dose of FLUVIRIN (lot number 112946P1). Concomitant therapy included ALTACE. On 15-SEP-2010, "24 hours after injection", the patient presented to ER with temperature 38.1 degrees centigrade, mild redness and tenderness in left deltoid area of PNEUMOVAX 23 injection, and into axilla. The patient was treated with doxycycline to prevent cellulitis. On an unspecified date, the patient recovered from the adverse events. No diagnostic laboratory tests performed. Additional information is not expected. This one of several reports received from the same source.
pt recv vax 14APR98 & tx for sinusitis & allerg rhinitis;15APR97 vomiting;16APR98 830AM noted swelling on rt had dorsum sparing deltoid & forearm;1030AM 16APR98 swelling better;no redness;seen @ clinic 16APR98 1045AM;
MODERNA COVID-19 VACCINE EUA Red rash, itchy and swollen area near injcetion site which developed on January 11, 2021.
Information has been received from an RN concerning a 25 year old white female pt who was exposed to a virus at work (prior to vaccination), who on 5/3/99, was vaccinated with a 1st dose of Hep-B vaccine recombinant IM in the right deltoid. The same day, post vax, the pt experienced stomach pain, achiness and tiredness. Two additional pts had similar experiences following exposure to Hep-B vaccine recombinant. Follow-up information from an RN reported that on 5/10/99, the pt recovered.
I received 2 doses of the Pfizer vaccine 3 weeks apart. I had no adverse effects after the first shot. A day or two after receiving the second dose I observed a rash on both ankles. There was no itch, but my skin became red and very dry. It has been 17 days since receiving the second dose and the rash has not gone away although it is a bit less red. I've had no ill effects from the rash.
pt recv vax 22JUL96 & immed p/vax pt arm felt heavy & felt like lead & pt fourth & fifth fingers were tingly;the nurse stated that pt had a small arm & the needle on the pre-filled syringe was a larger gauge needle then nl used to vax pt;
Hives all over body with heat radiating from hives. No temperature.  Follow up: No site reaction, Prescribed benadryl.
24 hours after administration the patient developed dizziness, lightheaded, photosensitivity, arm pain around injection site, and vomiting.; 24 hours after administration the patient developed dizziness, lightheaded, photosensitivity, arm pain around injection site, and vomiting.; 24 hours after administration the patient developed dizziness, lightheaded, photosensitivity, arm pain around injection site, and vomiting.; 24 hours after administration the patient developed dizziness, lightheaded, photosensitivity, arm pain around injection site, and vomiting.; This is a spontaneous report received from non-contactable reporter (Pharmacist).  A 42-year-old male patient received bnt162b2 omi xbb.1.5 (COMIRNATY (2023-2024 FORMULA)), on 19Sep2023 at 11:00 as dose 1, single (Lot number: HH7595) intramuscular, in right arm for covid-19 immunisation; influenza vaccine inact sag 4v (FLUCELVAX QUAD), on 19Sep2023 as dose 1, single (Lot number: 944458), in right arm for immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: VOMITING (non-serious), DIZZINESS (non-serious), PHOTOSENSITIVITY REACTION (non-serious), VACCINATION SITE PAIN (non-serious) all with onset 20Sep2023 at 08:00, outcome "recovered" and all described as "24 hours after administration the patient developed dizziness, lightheaded, photosensitivity, arm pain around injection site, and vomiting.". Therapeutic measures were not taken as a result of vomiting, dizziness, photosensitivity reaction, vaccination site pain. Additional information: Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19.
VOMITING; HURTING ALL OVER; SEVERE HEADACHES; NAUSEA; FEVER; This spontaneous report received from a consumer concerned a 42 year old male. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1820095, and expiry: 04-JUL-2021) dose was not reported, administered on 08-JUN-2021 for prophylactic vaccination. No concomitant medications were reported. On 09-JUN-2021, the subject experienced vomiting. On 09-JUN-2021, the subject experienced hurting all over. On 09-JUN-2021, the subject experienced severe headaches. On 09-JUN-2021, the subject experienced nausea. On 09-JUN-2021, the subject experienced fever. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from severe headaches, nausea, vomiting, hurting all over, and fever. This report was non-serious. This case, from the same reporter is linked to 20210619423, 20210619407 and 20210619408.
Administered a vaccine that has been refrozen; A spontaneous report was received from a nurse concerning a 36-year-old, male patient who received Moderna's COVID-19 vaccine (mRNA-1273) and was administered a vaccine that has been refrozen.   The patient's medical history was not provided. No relevant concomitant medications were reported.   On 28 Dec 2020, the patient received their first of two planned doses of mRNA-1273 (Lot: 025J20-2A) intramuscularly in the left deltoid for prophylaxis of COVID-19 infection.  On 31 Dec 2020, the nurse reported she had been storing the mRNA-1273 vaccines at -20 degrees Celsius but discovered that prior to the vaccine administration facility receiving the vaccines on 24 Dec 2020, they had been stored at 38.2 degrees Fahrenheit at another facility. No treatment information was provided.  Action taken with mRNA-1273 in response to the event was not reported.   The outcome of the event, administered a vaccine that has been refrozen, was considered resolved on 28 Dec 2020.; Reporter's Comments: This report refers to a case of medication error for mRNA-1273 (Lot: 025J20-2A), where refrozen vaccine was administered. There were no reported AEs associated with this case of out of specification product use.
Acute asthma attack; This is a spontaneous report from a contactable pharmacist. A 46-year-old female patient received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number: EK9231), intramuscular in the left arm on 15Jan2021 07:45 at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient was not pregnant at the time of vaccination. The patient was not diagnosed with COVID-19 prior to vaccination and had not been tested for COVID-19 since the vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient experienced acute asthma attack on 15Jan2021 08:00. This adverse event resulted in emergency room/department or urgent care. Therapeutic measures were taken as a result of acute asthma attack and included treatment with albuterol inhaler. Outcome of the event was recovering.
Patient received a dose of the Pfizer COVID-19 vaccine. Before he could exit the room to begin the observation period, the patient became unconscious and slipped into a seizure. Uncertain if it was hypersentivity coupled with vasovagal response, an epi pen was primed but not administered. The patient was unresponsive for a minute then came out of his apparent seizure
Almost immediately after the injection patient's arm began to feel cold and then numbness started from her upper arm down into her hand. The nurse who administered the vaccine inspected the injection site and did not see any issues. The patient stayed in the area for 50 minutes for monitoring. Her vital signs were taken and were within normal limits, she ambulated in the room and moved her right upper extremity freely including coordination exercises.  Numbness/coldness was still present at 13:42, but slowly improved.  As of 01/07/2021, patient's arm numbness has resolved but has had intermittent tingling in legs and feet.  Continuing to monitor.
Experiencing severe sudden sharp pain in right leg and food. Does not feel like a muscle ache but feels like my veins are getting twisted.
swollen shoulder part; Pretty high fever of 101; Feeling bad; This is a spontaneous report from a contactable consumer (patient). A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection), via an unspecified route of administration, on 27Feb2021 (Batch/Lot number was not reported) as dose number unknown, single for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. On Saturday night of 27Feb2021, the patient started feeling bad. On Sunday morning of 28Feb2021, the patient woke up with a pretty high fever of 101. She felt bad all day. The patient woke up the morning of 01Mar2021, and the fever was gone. The patient's shoulder part below the neck and closer to the base, between her neck and arm was now swollen (on the same side where she received the COVID vaccine). The patient wanted to make sure this was normal. The patient underwent lab tests and procedures on 28Feb2021, which included fever: pretty high fever of 101. The patient recovered from pretty high fever of 101 on 01Mar2021. The outcome for the rest of the events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
My first Pfizer vaccine was on May 15, 2021 and did not experience any reaction. The second Pfizer Vaccine was on June 5th, 2021. On June 18th, 2021 I started to feel pain and tingling in my left arm and left two fingers, as well as my face. I went to the emergency room and had a CT scan, EKG and blood test and everything came back normal. On June 21, 2021 I saw a Neurologist. I had an MRI done which found two very small incidental findings, one on my Left Thalamus and on my Pituitary. On June 25, 2021, I started to feel tingling in both legs from my knees down. On July 16, 2021 I started to get a really bad migraine and my face started to feel warm and my head felt hazy. This lasted until July 21, 2021. Since my symptoms started, I saw 3 Neurologists, Pituitary specialist and a Hematologist and none thought my symptoms were coming from the 2 findings and all other tests were normal. Things have gotten better but on occasion I feel tingling and muscle twitches in my legs.
PATIENT SKIPPED DOSE OF HUMIRA BECAUSE OF COVID EXPOSURE; PATIENT SKIPPED DOSE OF HUMIRA BECAUSE OF COVID EXPOSURE; Inappropriate schedule of vaccine administered; No Adverse Event; This spontaneous case was reported by a consumer and describes the occurrence of INTENTIONAL PRODUCT MISUSE (PATIENT SKIPPED DOSE OF HUMIRA BECAUSE OF COVID EXPOSURE), EXPOSURE TO SARS-COV-2 (PATIENT SKIPPED DOSE OF HUMIRA BECAUSE OF COVID EXPOSURE), INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Inappropriate schedule of vaccine administered) and NO ADVERSE EVENT (No Adverse Event) in an adult male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product ADALIMUMAB (HUMIRA) for an unknown indication.    No Medical History information was reported.   On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient started ADALIMUMAB (HUMIRA) (Subcutaneous) at an unspecified dose. On an unknown date, the patient experienced INTENTIONAL PRODUCT MISUSE (PATIENT SKIPPED DOSE OF HUMIRA BECAUSE OF COVID EXPOSURE), EXPOSURE TO SARS-COV-2 (PATIENT SKIPPED DOSE OF HUMIRA BECAUSE OF COVID EXPOSURE), INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Inappropriate schedule of vaccine administered) and NO ADVERSE EVENT (No Adverse Event). At the time of the report, INTENTIONAL PRODUCT MISUSE (PATIENT SKIPPED DOSE OF HUMIRA BECAUSE OF COVID EXPOSURE) and EXPOSURE TO SARS-COV-2 (PATIENT SKIPPED DOSE OF HUMIRA BECAUSE OF COVID EXPOSURE) had resolved and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Inappropriate schedule of vaccine administered) and NO ADVERSE EVENT (No Adverse Event) outcome was unknown.            This case was identified as part of a retrospective clean-up activity where certain emails received in the Moderna mailbox were missed to be booked-in.  No concomitant medication information was provided. It was unknown if patient was enrolled in a COVID-19 Vaccine Trial.  No treatment medication was provided.
Site: Redness at Injection Site-Mild, Site: Swelling at Injection Site-Mild, Systemic: Allergic: Rash (specify: facial area, extremeties)-Severe, Additional Details: PAITENT CAME FOR 2ND VACCINE AND I SAW A HUGE RED RASH ON HER ARM- I ASKED HOW SHE GOT IT AND SHE SAID IT WAS FROM HER COVID VACCINE- I ASKED IF SHE TOLD ANYONE ABOUT IT- SHE SAID NO- I URGED HER TO GO TO THE MD AND TO WAIT UNTIL THE RASH HAD CLEARED BEFORE GETTING THE 2ND VACCINE
presenting to the ED for evaluation of reported reaction to the COVID-19 vaccination. The patient reports undergoing her 1st COVID-19 vaccination recently and did not experience any reaction with this whatsoever. However, she received her 2nd vaccination yesterday and initially felt well, but awoke this morning with the feeling of "an elevated pulse", along with fatigue, nausea, nagging diffuse headache, left flank/low back pain, and soreness surrounding the vaccination site. No redness or significant swelling around the site. Also notes a brief episode of RLQ abdominal pain described as "cramping" earlier this morning that has since resolved. She has tried taking 500 mg Tylenol at 0800 without relief in her symptoms. No fevers, chills, dysuria, hematuria, chest pain, or shortness of breath. Patient reports being recently diagnosed with thyroid disease and began taking medications for this about two weeks ago. She denies any past medical history otherwise.
Hives on backs and arms. (I should say that hives are not rare for me- I experience them frequently) kind of like hot flashes.
On 11/12 I had tenderness and swelling in left breast. The following week I went in for an ultrasound and found a partially fluid filled cyst in my left breast. The doctor is watching it and want me to return in 6 months. My menstrual cycles stopped in September and didn't resume until mid November.
This spontaneous report was received from a pharmacist regarding to a patient of unknown age and gender. The patient's medical history and concurrent conditions were not reported. On an unknown date the patient was vaccinated with ZOSTAVAX lot #, dosing details unknown. Concomitant medications were not reported. On an unknown date, the patient diagnosed with shingles. The outcome of shingles was unknown. Product quality complaint (PQC) was not filed. Causality assessment was not provided. This is one of the two reports received from the same reporter. Additional information has been requested.
Discharge Provider:  Primary Care Provider: Admission Date: 7/3/2022 Discharge Date: 7/6/2022  PRESENTING PROBLEM: Weakness [R53.1] Vascular dementia with behavior disturbance (HCC) [F01.51] COVID-19 [U07.1]   HOSPITAL COURSE: The patient is a 66 y.o. male who presented to the ED for physical deconditioning and hyperglycemia. The patient was hospitalized 2 weeks ago for multiple subacute lacunar infarct together with cognitive impairment and vascular dementia.  There was initially some discussion of hospice but the patient's clinical status improved and he was discharged home with his wife. Unfortunately, there was difficulty obtaining pt's toujeo due to supply chain/pharmacy stock. Upon finally obtaining the toujeo, wife realized there were not needles given to administer the insulin. Pt had been off his long acting insulin for about a week which likely contributed to his overall weakness and increased urination. Wife tested positive for COVID three days prior to pt's admission. He tested positive for COVID on admission.   In the emergency department the patient's vitals were hemodynamically stable.  Laboratory workup notable for hyperglycemia with glucose 393 otherwise unremarkable.  He was admitted for PT/OT eval. Basal bolus insulin was resumed with quick improvement in blood sugar.  PT/OT recommended home with assist. Discussed at length with spouse who feels comfortable with the patient returning home as long as diabetes supplies are obtained so she can continue insulin dosing as instructed. Was consulted for assistance with diabetes supplies which were reviewed and rx sent at discharge.
throat is swelling; shortness of breath; feeling like I need to vomit; This spontaneous case was reported by a consumer and describes the occurrence of PHARYNGEAL SWELLING (throat is swelling), DYSPNOEA (shortness of breath) and VOMITING (feeling like I need to vomit) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Sep-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PHARYNGEAL SWELLING (throat is swelling), DYSPNOEA (shortness of breath) and VOMITING (feeling like I need to vomit). At the time of the report, PHARYNGEAL SWELLING (throat is swelling), DYSPNOEA (shortness of breath) and VOMITING (feeling like I need to vomit) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were provided. No treatment medications were provided.
Within an hour of the vaccine face was hot and muscle in face were painful in the jaws, sinuses up in nose felt weird and dry like menthol. Put ice on face. Took Tramadol. Having fatigue. Next day felt better, then started having brain fog difficulty remembering, vision is blurry, no energy and feel exhausted.
pt devel itching eyes, cough, wheezing;resp rate 16, wheezy sounding cough;swollen turbinates;sclerae are sl injected;hypersensitivity rxn to vax;inc cough, worsening wheeze;lungs show scattered expiratory wheeze & diffuse rhonchi;
Patient received vaccination in left deltoid muscle and approximately 6 hours later the area around joint of left arm/shoulder became very sore.
Skin rash on top of feet lasting 5 days, Blood in stool starting starting 02/17/2021 after 2 dose continueing untill 04/15/2021 colonoscopy performed on 04/03/2021 mild inflammation was found in the distal rectum, in the proximal sigmoid colon and in the mid sigmoid colon secondary to proctosigmoid colitis treted with a course of 40mg prednisone  starting 04/01/2021 decreasing by 10mg . bleeding increased on 04/12/2021 admitted to ER and hospitol until 04/14/2021. sigmoidoscopy performed on 04/13/2021 inflamation somewhat reduced.
Parents noted right thigh to be red, warm, swollen in an area of 5 x 7 cm. Child treated with Ibuprofen, ice to area. No clinic visit required.
Left upper back: Initially itching, day 2 redness and itching, day 3 itching, redness, swelling, raised pustules, day 4 same as day 3 with spreading.
became sick on 26OCT92 w/fever up to 104.3, runny nose, lethargic @ time, crying @ time; states temp keeps going up & down; pt seen in ER 28OCT92 was told pt having al allerg rxn to vax;
Information has been received from a healthcare worker concerning a 80 year old female with quinine, codeine and celecoxib allergy, osteoporosis, osteopenia, degenerative disc disease, degenerative joint disease, short term memory loss and hypertension who on 22-NOV-2006 was vaccinated with Pneumovax 23 (lot 3651357/0391f), 0.5 ml, IM in the left upper arm. Concomitant therapy included alendronate sodium (MSD), ADALAT and diazepam. Previous vaccination with Pneumovax 23 vaccine was on 06-NOV-1990. On 25-NOV-2006, the patient experienced cellulitis of the left upper arm (also reported as red, swollen, painful left upper arm). The patient went to the emergency room and was treated with antibiotics 3 days after an immunizaton with Pneumovax 23. On 26-NOV-2006, the patient experienced diarrhea. The patient was discharged from the hospital on 26-NOV-2006. On 28-DEC-2006, the patient recovered from the events of cellulitis and diarrhea. Additional information has been requested.
SORENESS IN ARM AT SHOT LOCATION AND FELT LIKE WENT DOWN ARM; This spontaneous report received from a patient concerned a male of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 180/50/20/ expiry: UNKNOWN) dose was not reported, administered on 19-MAR-2021 for prophylactic vaccination on Left Deltoid. No concomitant medications were reported. On MAR-2021, the subject experienced soreness in arm at shot location and felt like went down arm. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from soreness in arm at shot location and felt like went down arm on MAR-2021. This report was non-serious. Additional information was received from [reporter] on 23-MAR-2021.
Swelling and redness at injection site of (L) deltoid and biceps leading to warmth and erythema.
Severe body aches. Fever. Back pain. Nausea. Lethargy. Headache. Flu symptoms. Sweating. Cold sweats
Patient describes elevated heart rate starting about 2 am the morning after the vaccination. Heart rate remained elevated for almost 24 hours before subsiding without intervention. Heart rate hovered around 105 bpm until resolved.
fever 100.4, local erythema 3cm diameter & induration; 5 cm diameter over lt deltoids;